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Introduction
Protamine 1 and 2 (PRM1, PRM2) are small, arginine-
rich nuclear proteins that are involved in packing DNA
in spermatozoa [1]. The amino acid sequence of both
protamines was first determined by Ammer et al.
(1986). The PRM1 and PRM2 genes are localized on
chromosome 16p13.3. PRM1 is synthesized as a
mature protein product, which is composed of 50
amino acid residues.  PRM2 mRNA is translated as a
precursor protein consisting of 103 amino acids, which
undergoes proteolytic cleavage to form the 50 amino
acid mature protein [2]. The PRM1 and PRM2 are
transcribed in the post-meiotic haploid spermatid, dur-
ing early stages of spermiogenesis [3]. PRM1 and
PRM2 mRNAs have been found in round spermatids,
whereas the proteins are completely absent at this
stage [4,5]. The translation of PRM1 and PRM2 tran-
scripts is initiated and completed by the elongation
stage of spermatid development [6-8].
During mammalian spermiogenesis, the structure
of chromatin is permanentlly modified [9]. The first
step of this process takes place in haploid round sper-
matids and includes replacement of somatic histones
by transition proteins 1 and 2 (TNP1, TNP2). In the
phase of elongated spermatids, TNP1 and TNP2 are
replaced by protamines. After binding of protamines to
nuclear sperm chromatin, the process of gene tran-
scription is completely inactivated [9]. 
Abnormal spermatozoal PRM1/PRM2 protein ratio
can be contributed to abnormal chromatin condensa-
tion and increased DNA strand breaks, which result in
male infertility [9,10]. Sperm chromatin compaction is
crucial to protect sperm chromatin during transport
through the epididymis and female reproductive tract.
Abnormal chromatin remodelling during spermiogen-
esis results in chromatin that is prone to denaturation.
Miyagawa et al. (2005) found a relationship
between increased number of DNA strand breaks and
abnormalities of tail midpiece containing mitochon-
dria [11]. This finding indicates that an increased
number of DNA strand breaks may initiate the apop-
totic signalling pathway, inducing inactivation of mito-
chondria and immotility of spermatozoa [11]. There-
fore, we attempted to analyze the difference between
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PRM1 and PRM2 transcript presence in spermatozoa
of normozoospermic and asthenozoospermic men.
The mRNAs found in human mature spermatozoa
represent remnant transcripts, which survive the con-
densation of the spermatid nucleus and stay in human
ejaculated spermatozoa [12-14]. These transcript rem-
nants of mature sperm cells may correlate to gene
expression during spermatogenesis.
Using reverse transcription and real-time quantita-
tive PCR (RQ-PCR) analysis, we evaluated the num-
ber of PRM1 and PRM2 mRNAs in Percoll purified
spermatozoa from semen samples of normozoosper-
mic and asthenozoospermic donors. 
Materials and methods
Sperm purification method. Human ejaculates were obtained
from 70 healthy volunteers of proven fertility and normal semen
quality as assessed by WHO criteria (1999), and from100 astheno-
zoospermic men (Table 2). The main criterion for classification of
asthenozoospermic men was low sperm motility [15]. The semen
parameters, including motility, were assessed by computer-assisted
semen analysis (CASA) system [16]. Spermatozoa were then puri-
fied by centrifugation through discontinuous Percoll (Amersham
Bioscences, UK) density gradient (80:40, vol/vol). The purity of
the spermatozoa was examined by using an optical microscope
equipped with 100 x oil objective, and spermatozoa contaminated
by somatic or round cells were discarded. These separated sperma-
tozoa were subsequently used to isolate RNAs, which were reverse
transcribed into cDNA.
RQ-PCR analysis of PRM1 and PRM2 transcript contents in
spermatozoa. Each RNA sample was isolated from one million
spermatozoa according to Chomczyñski and Sacchi (1987), [17].
The purity of the RNA samples was verified spectrophotometrical-
ly at 260 and 280 nm. RNA was treated with DNase I (Promega
Co. Madison, USA) and reverse-transcribed into cDNA using ran-
dom hexamer priming and reverse transcriptase (RT) (Sigma Co.
St. Louis, USA). Quantitative analysis of PRM1 and PRM2 cDNA
was performed by RQ-PCR SYBR Green I analysis (Light Cycler,
Roche Diagnostics GmbH, Mannheim, Germany). The PRM1 and
PRM2 cDNAs were amplified using pairs of primers (Table 1, Fig-
ure 1). For amplification, 2 μl (corresponding to 105 spermatozoal
RNA) of cDNA was added to 18 μl of PCR mix containing HotS-
tartTaq DNA polymerase, reaction buffer, dNTP mix, SYBR Green
I dye, 2.5 mM MgCl2, and primers (Qiagen Inc. Valencia, Ca,
USA). Quantification of copy number was derived from a standard
curve of a known amount of synthetic DNA template. Since
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Table 1. Oligonucleotide sequences used for RQ-PCR analysis.
Table 2. Semen parameters of normozoospermic and asthenozoospermic men.
*P value was calculated using Fisher exact test. 
Fig. 1. Picture of agarose gel electrophoresis of RQ-PCR evalua-
tion of spermatozoal PRM1 and PRM2 transcripts. Amplification
products of spermatozoal cDNA of PRM1, PRM2, and GAPDH
are shown in lanes 1, 2, and 3, respectively. Lanes M and 4 repre-
sent molecular weight marker and negative control of amplifica-
tion, respectively.
GAPDH transcript exhibited similar levels in spermatozoa of both
normospermic and asthenozoospermic donors, we adjusted the
quantity of PRM1 and PRM2 transcripts in each sample to use the
same amount of GAPDH [18-20]. The levels of PRM1 and PRM2
mRNAs were expressed by the number of these transcripts per 106
spermatozoa or adjusted to fmol of GAPDH transcripts. 
Statistical analysis. Each of these experiments was performed at
least in triplicate. Results were estimated using Student's t-test and
one-way analysis of variance (ANOVA) with Newman-Keule's
post-hoc test. P value was determined by Student's t-test, with
p<0.05 as the level of significance. 
Results 
Using RQ-PCR analysis, we evaluated the number of
PRM1 and PRM2 transcripts in Percoll density gradi-
ent isolated spermatozoa from normozoospermic and
asthenozoospermic donor ejaculate. 
We found a higher content of PRM1 and PRM2 tran-
scripts in spermatozoa of normozoospermic men versus
asthenozoospermic men (Fig. 2). The median of PRM1
transcript contents in spermatozoa of normozoospermic
and asthenozoospermic males was  138 (range 109-162)
and 42 (range 12-86) copies per million sperm cells,
respectively (p<0.001), (Fig. 2A). The number of PRM2
transcripts in spermatozoa was also higher in normo-
zoospermic donors as compared to asthenozoospermic
men. The median of PRM2 mRNA contents in normo-
zoospermic and asthenozoospermic men was 119 (range
102-163) and 63 (range 18-116), (p<0.001) copies per
million of spermatozoa, respectively (Fig. 2A). We also
adjusted PRM1 and PRM2 transcript number to fmol
GAPDH mRNA, which confirmed significant differ-
ences between normozoospermic and asthenozoosper-
mic men (Fig. 2B).
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Fig. 2. Number of PRM1 and PRM2 transcript copies in spermatozoa isolated from normozoospermic and asthenozoospermic men. The
number of PRM1 and PRM2 transcript copies is presented per 106 sperm cells (A) or per fmol of GAPDH (B). aP and bP represent sta-
tistical differences between PRM1 and PRM2 transcript contents in spermatozoa from normospermic and asthenozoospermic donors,
respectively. 
Discussion
During spermiogenesis, the haploid round spermatids
undergo an elongation phase, cytoplasmic droplet
rejection, and eventually differentiation into mature
spermatozoa [21,22]. There is no de novo synthesis of
RNA in human sperm [23]. However, human mature
spermatozoa contain a subset population of RNA,
which has also been found in human testes. Microarray
analysis has revealed that about 3000 different tran-
scripts exist in ejaculated spermatozoa [24-26]. 
Expression of protamines is essential in spermato-
genesis and male fertility. They are needed for proper
sperm chromatin compaction, which contributes to
resistance of spermatozoal chromatin to denaturation.
Male infertility is generally characterised by dysfunc-
tions in processes of penetration, adhesion, and fusion
with oocyte. Ahmadi et al. (1993), using hamster egg
test, has proved that destruction of the protamines,
using dithiothreitol as a disulfide-reducing reagent,
leads to reduction of sperm binding to oocyte and sper-
matozoal penetration ability [27]. Distinct levels of
spermatozoal PRM1 and PRM2 mRNAs were found
in spermatozoa of fertile and infertile men [9]. More-
over, Carrell et al. (2001) have shown that PRM2 was
absent in 13 of 75 infertile patients, although this pro-
tamine was found in all 50 fertile men in their study
[28]. They also found that low levels of PRM2 corre-
lated with low sperm counts, low motility, and mor-
phological abnormalities [28]. In contrast, Steger et al.
(2003) did not find differences in PRM2 transcript lev-
els in spermatozoa isolated from men with impaired
spermatogenesis compared with men with normal
spermatogenesis [29]. However, they observed signif-
icantly decreased PRM1 transcript contents in the
group of patients with impaired smermatogenesis [29]. 
Our results first showed a decrease in both PRM1
and PRM2 transcripts in spermatozoa from astheno-
zoospermic men compared to the same transcripts in
spermatozoa from normozoospermic men. 
Protamines play a crucial role in sperm chromatin
condensation and protection of the paternal genome
from DNA damage [30-32]. Low levels of PRM1 or
PRM2 may lead to DNA damage accumulation in
sperm, morphological abnormalities, and initiation of
apoptotic pathway, inactivating mitochondria and
decreasing sperm motility [11]. 
Our results first described significantly decreased
levels of PRM1 and PRM2 mRNAs in spermatozoa
from men with asthenozoospermia. We presume that
decreased levels of both PRM1 and PRM2 transcripts
in spermatozoa from this group of patients may be
associated with lower sperm motility and reduction of
reproductive ability of these donors.  Further studies
are required to determine molecular mechanisms respon-
sible for PRM1 or PRM2 transcript reduction in sperma-
tozoa from asthenozoospermic donors.
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